NV5 expects full-year earnings in the range of $1.27 to $1.37 per share, with revenue in the range of $1.03 billion to $1.05 billion. This story was generated by Automated Insights ( using data from ...

Adaptive Biotechnologies Corp. ADPT) on Thursday reported a loss of $29.9 million in its first quarter. On a per-share basis, the Seattle-based company said it had a loss of 20 cents.